In addition, PP2A may drive tau hyperphosphorylation, as its activity is significantly compromised in AD brains and animal models of FTD (Liu et al., 2005; Tanimukai et al., 2005; Khandelwal et al., 2012). This evidence concerns the gene MAPT and Alzheimer disease.